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DF-1 is a continuous cell line of chicken embryo fibroblasts. The cells are free of endogenous sequences related to avian
sarcoma and leukosis viruses and have normal fibroblastic morphology. DF-1 cells support the replication of avian
retroviruses; diverse oncogenes induce foci of oncogenic transformation on monolayers of DF-1, and avian leukosis viruses
of envelope subgroups B, D, and C induce cell death and form plaques. The new cell line will greatly facilitate studies on
oncogenic transformation and cell killing by avian viruses. © 1998 Academic Press
INTRODUCTION
Research on avian retroviruses has played an impor-
tant role in the development of the retrovirus field and
has often defined the leading edge of retrovirology. The
focus assay, a first quantitative in vitro measurement of
oncogenic transformation, the discovery of reverse tran-
scriptase, and the identification of the first retroviral on-
cogene product were all made with an avian virus (Temin
and Rubin, 1958; Baltimore, 1970; Temin and Mizutani,
1970; Brugge and Erickson, 1977). Other seminal devel-
opments originating in avian virology were the demon-
stration that acutely oncogenic retroviruses are com-
monly defective for replication, determination of retroviral
genome size and maps, retroviral recombination and
phenotypic mixing, endogenous viruses, temperature-
sensitive mutants affecting oncogenic transformation,
and the cellular origin of the retroviral oncogenes (Hana-
fusa et al., 1963; Payne and Chubb, 1968; Weiss and
Payne, 1971; Vogt, 1971; Weiss et al., 1973; Beemon et al.,
1974; Billeter et al., 1974; Duesberg et al., 1975; Coffin and
Billeter, 1976; Stehelin et al., 1976; Wang et al., 1976a,b).
However, avian retrovirology has long had a peculiar
impediment: the absence of a continuous cell line that is
nontransformed and free of endogenous and exogenous
viral genomes. Although there have been early and more
recent reports on chicken embryo cell lines (Carrel, 1912;
Kaaden et al., 1982), none has resulted in a widely avail-
able tool for virus studies. The only continuous avian cell
lines in use are frankly transformed either by Marek’s
disease herpesvirus (Akiyama et al., 1973; Nazerian and
Witter, 1975; Nazerian et al., 1977), Rous sarcoma virus
(Dinowitz, 1977; Gionti et al., 1989; Barald et al., 1997), or
a chemical carcinogen (Moscovici et al., 1977), and they
are therefore of limited utility. This deficiency has been a
significant handicap for molecular biological studies. In-
deed, analysis of important molecular aspects of retro-
viral infection depended on the availability of continuous
cell lines, and this requirement has generally favored the
use of mammalian viruses (Hughes et al., 1978; Steeg
and Vogt, 1990; Berkowitz and Goff, 1993; Alin and Goff,
1996). Recently, a continuous line of chicken embryo
fibroblasts, DF-1, has been developed (Foster, 1998). It is
derived from an EV-0 embryo and is free of endogenous
sequences related to the avian sarcoma and leukosis
virus (ALSV) group. It is not transformed but has en-
hanced growth potential compared to secondary embryo
fibroblasts. The present report describes the susceptibil-
ity of DF-1 to transformation by various oncogenes and to
infection by ALSV. Related aspects of DF-1/ALSV inter-
action are explored in a companion paper (Schaefer-
Klein et al., 1998).
RESULTS
Diverse oncogenes induce transformed cell foci in
cultures of DF-1 cells
Tables 1 and 2 summarize the results of transforma-
tion assays on DF-1 cells. Oncogenes that code for
cytoplasmic proteins, with the exceptions of crk and
v-abl, induce distinct transformed cell foci in DF-1. These
oncogenes share transforming properties on CEF and
DF-1: they induce swelling and rounding of the cell and
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pronounced multilayering within the focus. These cellu-
lar changes in morphology and growth pattern mark
these oncogenes as “strong” transformers. DF-1 cells
have higher saturation densities than CEF (2820 6 154
versus 736 6 51 cells/mm2 reached under DC3 agar
overlay on day 4 after seeding). Therefore, focus forma-
tion on DF-1 must occur against an increased back-
ground of multilayering by uninfected cells. Most nuclear
oncogenes do not induce foci on DF-1 cells. The two
exceptions are myc and e2f; both also induce cell death
and aberrant growth.
Figures 1 and 2 illustrate transformed cell morpholo-
gies and growth patterns induced by some of the onco-
genes in DF-1 cultures. In most instances, the foci in
DF-1 resembled those in CEF. However, there were some
notable exceptions. On DF-1 clone P3B, the c-mos onco-
gene induced the formation of cell rounding as well as
multinucleated cells that originated by cell fusion or
endomitosis (Fig. 2C). These cell types are also found in
CEF and in chicken yolk sac macrophage cultures ex-
pressing c-mos. In contrast, clone 32 of DF-1 responded
to expression of c-mos by becoming elongated and swol-
len-fusiform (Fig. 1D); multinucleated cells were not prev-
alent. These two types of mos-induced transformation
illustrate the extremes of clonal variation within the DF-1
cell population. Foci induced by myc consisted of a
mixed population of rounded, healthy appearing trans-
formed cells and dying cells with fragmented nuclei. This
observation is in accord with the transforming and ap-
optosis-inducing potential of myc (Dolnikov et al., 1996;
Fulton et al., 1996; Petropoulos et al., 1996). Cell-killing
activity predominated in MH2, a virus that contains both
the myc and the mil (avian homolog of raf) oncogenes.
Similarly, the foci induced by e2f contained a preponder-
ance of dying cells. The E2F protein can have different
effects on cells depending on the level of expression
(Kowalik et al., 1995; DeGregori et al., 1997; Givol et al.,
1998). Surprizingly, NK24, a fos-carrying avian retrovirus,
also induced cell death rather than oncogenic transfor-
mation.
Construct-dependent transformation by Jun
The jun oncogene was originally derived from avian
sarcoma virus 17 (ASV17). In this viral genome, it is fused
at its 59 terminus to viral gag sequences generating a
Gag-Jun fusion protein. Tests with ASV17 in DF-1 cultures
failed to induce foci of distinctly transformed cells. How-
ever, when cells of ASV17-infected DF-1 agar colonies
were plated onto plastic, they showed the fusiform and
needle-like morphology characteristic of Jun-transformed
CEF. (Maki et al., 1987). Additional experiments with Jun
constructs in the RCAS (Hughes et al., 1987; Federspiel
and Hughes, 1997) and pRV vectors (Kataoka et al., 1993)
also revealed a direct focus-forming ability in DF-1 cul-
tures. The active constructs were RCAS-vJ1 and pRV-vJ.
Both contain the viral Jun of ASV17 but without the Gag
sequences. RCAS-vJ0, which, like ASV17, expresses the
Gag v-Jun fusion protein, did not induce foci. These
observations suggest that fusion to Gag may reduce
focus-forming ability of Jun in DF-1 cultures. The reason
for this reduction remains to be determined; it could be
related to protein synthesis or protein stability.
Comparison of efficiencies of focus formation
Table 3 summarizes the efficiencies of focus formation
by selected oncogenes on DF-1 cells relative to second-
ary CEF cultures. Several oncogenes, namely, src, erbA/
erbB, sea, DSH3-abl, mafQ5H, and e2f, show efficiencies
TABLE 2
Focus Formation Induced by Nuclear Oncogenes on DF-1 Cells
Oncogenes
Focus
formation
Representative
titer (FFU/ml)
Viruses and
constructs tested
v-gag-jun No ASV17, RCAS-vJ0
v-jun Yes 1 3 106 RCAS-vJ1
junD No RCAS-JUN D
v-qin No ASV31
v-myb/ets No E26
v-myb No AMV
pax3fkhr No RCASBP-PAX3-FKHR
c-myc Yes 9 3 106 RCAS-c-MYC
v-myc Yes 5 3 105 RCAS-v-MYC
v-fosa No 4 3 106 NK24
v-maf No AS42
v-maf Q5H Yes 2 3 104 pRV-MAF Q5H
e2f a No 8 3 106 RCASBP-E2F
v-mil/myca No 3.6 3 106 MH2
a Predominantly cell death.
FFU, focus-forming units.
TABLE I
Focus Formation Induced by Cytoplasmic Oncogenes on DF-1 Cells
Oncogenes
Focus
formation
Representative
titer (FFU/ml)
Viruses and
constructs tested
v-erbA, erbB Yes 1 3 103 AEV
v-sea Yes 6 3 105 S13
v-src Yes 8 3 106 PR-RSV-A, -B, -C;
BH-RSV(RPV)
v-crk No ASV1
c-mos Yes 5 3 107 RCAS-MOS
v-p3k Yes 3 3 104 ASV-16, RCASBP-v-P3K
v-abl No RCAS-v-ABL
DSH3-abl Yes 5 3 104 RCAS-DSH3-ABL
v-fps Yes 2 3 105 PRC-II
v-yes Yes 6 3 103 Y73
akt-m Yes 9 3 105 RCASBP-AKT-M
Note. Comprehensive tables of retroviral oncogenes and their deri-
vations may be found in Hunter (1997) and Rosenberg and Jolicoeur
(1997). e2f encodes the human cellular E2F-1 protein. Viruses and
constructs listed in this table are described in Materials and Methods.
FFU, focus-forming units.
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of focus formation on DF-1 that differ from the efficien-
cies on CEF by factors of ,10. These differences are
within 2 SDs of the mean efficiencies determined with
CEF from different embryos. Other oncogenes, however,
showed efficiencies of focus formation on DF-1 that de-
viated from those on CEF by factors of .10. Increased
efficiencies were seen with c-mos, v-myc, c-myc, p3k,
and ras. For mos and v-myc, the differences approach
100-fold. In contrast, fps and yes transformed CEF much
better than DF-1. The very high difference between CEF
and DF-1 seen with the combined mil/myc oncogenes
expressed by MH2 virus may represent an enhancement
of apoptosis by the cooperation of the oncogenes or an
excess of a cytopathic avian leukosis helper virus. Such
a helper virus may cause no detectable cell damage in
CEF cultures but induce death of DF-1 (see below).
Indeed, the virus titer given for MH2 is based on com-
bined plaque and focus counts. The reasons for the
increased or decreased susceptibility of DF-1 to these
oncogenes remain to be determined.
Cell death induced in DF-1 cultures by avian
leukosis virus
The cytopathic effect of fos and mil/myc in DF-1 cells
suggested an increased susceptibility of the cell line to
cell death-inducing viral products. This possibility was
further investigated by studying the effects of avian leu-
kosis viruses on DF-1. These viruses came from different
envelope subgroups, some of which are known to have
FIG. 1. Transformation of DF-1 cells clone 32 by retroviral oncogenes. Live cells observed with phase contrast optics and photographed at 1003
magnification. Uninfected DF-1 clone 32 cells on day 5 (A) and day 8 (B) after seeding. (C) Transformation by v-ras. (D) Transformation by c-mos. (E)
Transformation by c-myc. (F) Transformation by v-src.
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cytopathic potential for CEF (Graf, 1972; Brojatsch et al.,
1996). These experiments are summarized in Table 4.
Under the present culture conditions, none of the avian
leukosis viruses induced detectable changes in cell
growth or morphology in CEF. In contrast, DF-1 cells
were severely affected by viruses of subgroups B, D, and
C, which induced extensive cell death at high virus con-
centrations and individual, readily countable plaques at
low concentrations (Figs. 3 and 4). The number of these
plaques was directly proportional to the virus concentra-
tion. DF-1 cells can therefore be used for rapid and
quantitative assays of subgroup B, D, and C avian leu-
kosis viruses. The dying cells in these cultures contained
fragmented nuclei and were positive in the TUNEL assay,
suggesting that they were undergoing apoptosis.
Retroviral replication in DF-1 cells
The ability of DF-1 cells to replicate avian retroviruses
was investigated in a one-step growth experiment. Sec-
ondary CEF and DF-1 cells were seeded onto separate
60-mm dishes at 1 3 106 cells per dish and inoculated at
a multiplicity of 1.0 with the Prague strain of Rous sar-
coma virus, envelope subgroup A. The cells were kept in
a medium consisting of 93% Ham’s F-10, 5% calf serum,
and 2% L-glutamine-penicillin-streptomycin. Harvests of
FIG. 2. Transformation of DF-1 cells clone P3B cells by retroviral oncogenes. Live cells observed with phase contrast optics and photographed at
1603 magnification. (A) Uninfected DF-1 clone P3B. (B) Transformation by v-ras. (C) Transformation by c-mos. (D) Transformation by v-src. (E)
Transformation by c-myc. (F) Transformation by v-myc.
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the culture fluids were taken at daily intervals and as-
sayed for focus formation on secondary CEF. Figure 5
shows the results. DF-1 cells support the growth of Rous
sarcoma virus, producing amounts of virus that by days
3 and 4 postinfection are roughly equivalent to virus
yields from CEF.
DISCUSSION
The properties of DF-1 will encourage widespread use
of this cell line for work with diverse avian viruses,
especially for molecular biological studies with avian
retroviruses. DF-1 cells are susceptible to transformation
by numerous oncogenes and efficiently replicate avian
retroviruses. Some of the oncogenes that do not induce
well defined oncogenic foci in DF-1 cultures may, similar
to gag-jun of ASV17 and of RCAS-vJ0, induce cellular
transformation that can be recognized on subcloning of
the oncogene-expressing cells. DF-1 cells show an in-
creased saturation density, and because of this back-
ground of uninfected cell growth, foci of transformed
cells become discernible only if distinct changes in cell
shape or excessive multilayering are induced by the
oncogene. The requirements for focus formation in DF-1
cells appear more stringent than the ones in CEF and
may constitute the primary cause for the failure of some
oncogenes to induce foci in DF-1 cultures. However,
other reasons for inactivity have not been ruled out and
should be investigated; these include low levels of on-
cogene expression or instability of the oncogene product
or a specific resistance of DF-1 cells to the growth
stimulatory signal issued by a particular oncogene. High
steady state levels of an oncoprotein may be critical; they
provide a likely explanation for the differences in focus-
forming ability observed with various Jun constructs.
The high susceptibility of DF-1 cells to the cell
death-inducing activity of certain avian retroviruses
clearly distinguishes DF-1 from CEF and will greatly
facilitate investigations of virus-induced apoptosis.
Some of the observations on cell killing reported here
must be examined further. Although the apoptosis-
inducing activities of envelope subgroup B and D
viruses are known to be mediated by a cell surface
receptor related to the receptor for tumor necrosis
factor (Brojatsch et al., 1996), the cell-killing activities
of envelope subgroup C viruses are unexpected and
unexplained. Barring a trivial explanation (e.g., con-
tamination with subgroup B or D viruses), the cell-
killing activity of envelope subgroup C could reveal
interesting new aspects of apoptosis. The cytopatho-
genicity of the fos-expressing avian retrovirus NK24
could also be caused by an envelope component or by
the fos oncogene proper, which can function as a
mediator of stress-induced apoptosis (Pruschy et al.,
1997). Similar considerations apply to the extreme
cell-killing effect of MH2. It could result from the com-
bination of the oncogenes mil (raf) and myc expressed
by this virus, from a subgroup B or D envelope com-
ponent, or from both. Occasionally, we have seen cell
death, presumably apoptosis, in DF-1 cultures even
with src. This discussion makes it clear that the ex-
quisite susceptibility of DF-1 cells to viral cytopathic
effects raises several interesting new questions that
relate to molecular mechanisms of apoptosis; it also
suggests that this cell line will prove useful in the
study of avian and mammalian cytopathic viruses.
TABLE 4
Plaque Formation Induced by Avian Leukosis Viruses on DF-1 Cells
Avian leukosis
virus
Envelope
subgroup
Representative
plaque titer (PFU/ml)
RAV-1 A no CPE
RAV-3 no CPE
RAV-2 B 5 3 105
RAV-6 1 3 106
tdPRB 2 3 105
RAV7 C 1 3 105
tdB77 2 3 104
CZAV D 3 3 104
RPV F no CPE
GPV G no CPE
Abbreviations: CPE, cytopathic effect; RAV-1, Rous associated vi-
rus-1; tdPRB, transformation-defective Prague strain of Rous sarcoma
virus envelope subgroup B; tdB77, transformation-defective avian sar-
coma virus B77; CZAV, Carr-Zilber-associated virus; RPV, ring neck
pheasant virus; GPV, golden pheasant virus (Duesberg and Vogt, 1970;
Duesberg and Vogt, 1973; Duff and Vogt, 1969; Fujita et al., 1974; Graf,
1972; Weiss, Mason, and Vogt, 1973).
TABLE 3
Efficiencies of Focus Formation on DF-1 Cells
Oncogene
FFU or PFU/ml on DF-1
FFU or PFU/ml on CEF a
src 1.0
sea 3.0
p3k 10.0
DSH3-abl 2.5
fps 0.08
yes 0.06
ras 12.0
mos 75.0
c-mycb 11.1
v-mycb 84.0
v-jun 2.5
e2f c 3.0
mil/myc (MH2)c 1440.0
erbAerbB 0.2
a Data are from a representative experiment. PFU, plaque-forming
units; FFU, focus-forming units.
b Tranformation and cell death.
c Predominatly cell death.
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MATERIALS AND METHODS
Viruses and constructs
Avian erythroblastosis virus (AEV) is of the ES4 strain;
it carries the erbA and erbB oncogenes (Lai et al., 1979,
1980; Debuire et al., 1984). The Prague strains of Rous
sarcoma virus envelope subgroups A, B, and C have
been described (Duff and Vogt, 1969). The Bryan high
titer strain of Rous sarcoma virus with ring-necked
pheasant virus helper, BH-RSV(RPV), has also been char-
acterized previously (Fujita et al., 1974). ASV-1 is an avian
sarcoma virus isolated from a spontaneous tumor. It
contains the crk oncogene (Tsuchie et al., 1989). PRCII
stands for Poultry Research Centre II; this virus carries
the fps oncogene, and Y73 contains the yes insert (Neil
et al., 1981; Kitamura et al., 1982). ASV-17 and ASV-31
with the oncogenes jun and qin, respectively, have been
characterized recently (Maki et al., 1987; Li and Vogt,
1993). E26 and avian myeloblastosis virus (AMV) strain
BAI-A are acute avian leukemia viruses carrying the
myb/ets and the myb oncogene, respectively (Langlois et
al., 1966; Nunn et al., 1983). The fos- and maf-carrying
viruses NK24 and AS42 have been isolated and studied
by Kawai and coworkers (Goto and Kawai, 1987; Kawai et
al., 1992; Kataoka et al., 1993). S13 is an avian erythro-
blastosis virus that carries the sea oncogene (Hayman et
al., 1985; Woods et al., 1986; Smith et al., 1989). RCAS is
an avian retroviral expression vector based on the ge-
nome of the Prague strain of Rous sarcoma virus
(Hughes et al., 1987; Petropoulos and Hughes, 1991;
Federspiel and Hughes, 1997). Cells transfected with
RCAS constructs release infectious retroviruses that ex-
press the insert. Two versions of this vector were used,
RCAS and RCASBP. In the latter, the polymerase gene
has been replaced by that of the Bryan high titer strain of
Rous sarcoma virus. The two versions are noted in the
constructs listed in Tables 1 and 2. The jun-expressing
constructs RCAS-vJ1 and RCAS-vJ0 have been described
previously (Bos et al., 1990) The RCAS constructs with
chicken c-mos (RCAS-MOS), chicken c-myc (RCAS-c-
MYC), and v-myc (RCAS-v-MYC, derived from avian my-
elocytoma virus MC29; Mladenov et al., 1967; Duesberg
and Vogt, 1979) were kindly provided by Stephen Hughes.
They have been characterized previously (Schmidt et al.,
1988; Petropoulos et al., 1996). The v-abl and DSH3 abl
clones have been described; they were also expressed
by RCAS (Kelliher et al., 1990; Maru et al., 1996). RCAS-
junD carries a mutationally activated form of the chicken
junD gene (Hartl and Vogt, 1992). RCAS-v-p3k and ASV-16
carry a homolog of the catalytic subunit of phosphoino-
sitide-3 kinase as an oncogene (Chang et al., 1997).
RCAS-AKT-m contains the myristylable form of the mu-
rine akt oncogene (Bellacosa et al., 1991; Aoki, 1998).
RCAS-PAX3-FKHR expresses a fusion protein consisting
FIG. 3. Cytopathic effects of the envelope subgroup B virus RAV-2. Live cells observed with phase contrast optics and photographed at 1003
magnification. (A) Sparse culture with beginning cytopathic changes that include cell vacuolization and cell surface blobbing. (B and C) Later stages
of the same culture show increased cell death but also persistent cell growth. (D) Normal DF-1 cells.
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of the DNA binding domain of PAX3 and the transcription
regulatory domain of the FKHR (forkhead related) gene.
This fusion protein is derived from a t(2,13) translocation
that occurs in human rhabdomyosarcoma. The RCAS-
PAX3-FKHR construct transforms secondary CEF cul-
tures (Scheidler et al., 1996). maf Q5H is a mutated maf
oncogene that is more potent in transformation than the
viral maf of AS42; it is expressed in the pRV retroviral
vector (Kataoka et al., 1993). RCAS-E2F expresses the
human e2f gene.
Cells
Primary chicken embryo fibroblasts were prepared by
standard techniques (Vogt, 1969) from 10-day embryos
supplied by SPAFAS, Inc. (Preston, Connecticut). For vi-
rus assays, they were passaged once and are referred to
as CEF. These cells are susceptible to envelope sub-
groups A, B, C, D, and F of ASLVs and contain genomic
sequences related to ASLV genomes (EV sequences).
DF-1 cells are a continuous line of fibroblasts derived
from an EV-0 chicken embryo lacking endogenous ASLV-
like sequences (Foster, 1998). The line developed spon-
taneously from a high density seeding of fibroblasts from
a 10-day embryo. Cells of this seeding were continuously
passaged and split when confluent. Eleventh-passage
cells appeared highly senescent and were seeded onto
30 plates. The cells were refed for several weeks, and
FIG. 4. Plaques produced by avian leukosis viruses. The cells are fixed and stained with crystal violet. (A-C) Photographed with bright field
illumination at 253 magnification. (D and E) Photographed without magnification. (A) RAV-2, (B) tdB77, (C) MH2, (D) RAV-2, and (E) tdB77.
FIG. 5. One-step growth of PR-RSV-A in CEF compared with DF-1
cells.
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eventually a small population of cells began dividing on
one of the plates. Initially, the cells grew slowly and had
to be transferred at high seeding density, but by the 40th
passage, they grew more rapidly and formed a homoge-
neous population (Foster, 1998). DF-1 cells were origi-
nally grown in Dulbecco’s modified Eagle’s medium) sup-
plemented with 10% fetal calf serum. During recent pas-
sages, they were switched to cloning medium consisting
of 83% Ham’s F-10, 10% calf serum, 4.5% chicken serum
(heated to 56°C for 60 min), 1% of 1003 vitamin solution,
1% of 1.8 mM folic acid, and 0.5% dimethylsulfoxide. In
this medium, the DF-1 cells showed a more uniform,
flatter, and fibroblast-like morphology and more rapid
growth. Several clones of DF-1 cells were established
and were selected for flat adherent cell shape and
growth properties that led to a minimum of multilayering.
Focus assays
Focus assays were carried out on CEF as described
previously (Vogt, 1969). Six-well microplates (35-mm di-
ameter) were used with 5 3 105 cells seeded per well.
The absorption and penetration medium consisted of
93% Ham’s F-10, 5% calf serum, and 2% of 1003
L-glutamine-penicillin-streptomycin. This medium was
replaced on the day after inoculation with nutrient agar
overlay (DC3) that contained 43% of 23 Ham’s F-10, 3%
fetal calf serum, 1% heat-inactivated chicken serum, 8.5%
tryptose phosphate, 1% of 1003 L-glutamine-penicillin-
streptomycin, 1% dimethylsulfoxide, and 42.5% of a 1.5%
solution of SeaPlaque agar. The procedure was modified
for DF-1 cells. Cell seeding was reduced to 3 3 105 cells
per well, and cell growth had to be slowed by reducing
the concentration of fetal calf serum in the nutrient agar
overlay (DC2) to 2.3%. With these modifications, foci
could be scored on DF-1 up to 2 weeks after infection.
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